The breast biopsy devices market is gaining momentum as awareness of breast cancer screening and diagnostic technologies continues to grow worldwide. In 2023, the market was valued at USD 1.8 billion, and it is projected to nearly double to USD 3.4 billion by 2030, representing a CAGR of 9.7% during the forecast period (2024–2030). This growth reflects...